Lamivudine plus either Atazanavir/ritonavir, Darunavir/ritonavir or Dolutegravir as switch strategies in HIV-positive, virologically-suppressed patients: a comparison - Alberto Borghetti

European HIV Clinical Forum 2016

Outcomes of HIV-exposed infants before and after implementing Option B+ PMTCT guidelines in Kampala, Uganda: a retrospective cohort study | Dr. P. Elyanu

International Workshop on HIV & Pediatrics 2016

Cumulative tenofovir exposure is associated with decreased BMD in young and old HIV-infected adults on tenofovir based regimens - Sharon Seifert, PhramD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Rifampin (RIF) Decreases Cabotegravir (CAB) Exposure following Oral Coadministration - Dr. Susan Ford

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Hepatitis C virus Infection in Children with and without HIV ‐ Epidemiologynsmission (MTCT) of HIV during Breastfeeding (BF) - Claire Thorne, BA, MSc, PhD

International Workshop on HIV & Pediatrics 2015

Update on New WHO Treatment Guidelines | Philippa Easterbrook

International Viral Hepatitis Elimination Meeting (IVHEM) 2023

#8_ShalenaNaidoo_ A Longitudinal Assessment of the Impact of Antiretroviral Therapy and HIV_ Slides

International Workshop on HIV & Pediatrics 2022

Successes and Challenges Over the Last Decade in Research on Prevention of Mother-to-Child HIV Transmission - Lynne Mofenson, MD

International Workshop on HIV & Women 2020

IVHEM 2020 Abstract Book

Strategies for hepatitis C elimination- Francesca Ceccherini– Silberstein, PhD

Andean Pacific Workshop on HIV & Hepatitis 2017